Impact of COVID-19-related methadone regulatory flexibilities: views of state opioid treatment authorities and program staff.

Shannon Gwin MitchellJulia JesterJan GryczynskiMelanie WhitterDouglas FullerCaroline HalstedRobert P Schwartz

Published in: Addiction science & clinical practice (2023)

The experienced reflections of SOTAs and OTP providers on methadone practice changes during the COVID-19 pandemic offer insights on SAMHSA's proposed revisions to its OTP regulations. Trial registration Clinicaltrials.gov # NCT04188977.

Keyphrases

coronavirus disease
quality improvement
sars cov
healthcare
primary care
chronic pain
clinical trial
pain management
study protocol
transcription factor
phase iii
randomized controlled trial
phase ii
combination therapy
respiratory syndrome coronavirus
smoking cessation